HIT Consultant November 14, 2022
What You Should Know:
– Curavit Clinical Research, a virtual contract research organization (VCRO) that specializes in decentralized clinical trials (DCTs) announced it raised $5M in Series A funding to accelerate its growing portfolio of research in the global digital therapeutics (DTx) market. The round was led by Osage Venture Partners with additional investment from Royal Street Ventures and Narrow Gauge Ventures.
– The new funding will be used to expand the company’s DCT capabilities, partnerships, and market adoption of Curavit’s virtual CRO services and platform for prescription and non-prescription digital therapeutics trials.
In addition, Curavit joined...
Today's Sponsors
Today's Sponsor